Alistair T R Sim

Author PubWeight™ 10.20^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers.	Cancer Res	2010	2.06
2	Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.	J Med Chem	2002	1.44
3	Phosphorylation of CaMKII at Thr253 occurs in vivo and enhances binding to isolated postsynaptic densities.	J Neurochem	2006	1.02
4	Tyrosine hydroxylase dephosphorylation by protein phosphatase 2A in bovine adrenal chromaffin cells.	Neurochem Res	2002	0.86
5	Protein phosphatases 1 and 2A transiently associate with myosin during the peak rate of secretion from mast cells.	Mol Biol Cell	2002	0.86
6	Role of protein phosphatase 2C from bovine adrenal chromaffin cells in the dephosphorylation of phospho-serine 40 tyrosine hydroxylase.	J Neurochem	2003	0.85
7	Src family tyrosine kinases differentially modulate exocytosis from rat brain nerve terminals.	Neurochem Int	2006	0.83
8	Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation.	Cell Signal	2010	0.82
9	Two modes of exocytosis from synaptosomes are differentially regulated by protein phosphatase types 2A and 2B.	J Neurochem	2003	0.80
10	The first two cantharidin analogues displaying PP1 selectivity.	Bioorg Med Chem Lett	2002	0.77